Polfa Warszawa S.A. Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Polfa Warszawa provides pharmaceutical products including acard, acenocoumarol, adrenalin, allertec, anticol, atropinum sulfuricum, betadrin, bimatoprost, biodacin, biotebal, and more.

Company Highlights
Year Founded

1824

icon-altEmployees

145

Location (HQ)

POL

Monthly Website Visitors

2.3K

icon-altMoM Headcount Growth

-1.36%

icon-altYoY Headcount Growth

-27.12%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Manufacturing

Pharmaceutical

Medical Device